Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewsWire · 3 days ago
Why Is Sight Sciences Stock Gaining Thursday?Benzinga · Oct 15, 2026
Sight Sciences, Inc. (NASDAQ:SGHT) Stock Has Consensus Price Target of $8.38Defense World · Oct 12, 2026
Sight Sciences: Signs Of Progress, But Plenty Of Work RemainsSeeking Alpha · Oct 9, 2026
Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual MeetingGlobeNewsWire · Oct 1, 2026
Sight Sciences (NASDAQ:SGHT) Hits New 1-Year High – Should You Buy?Defense World · Sep 30, 2026Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED).
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | -$0.18 | -$0.08 | Beat |
| May 6, 2026 | -$0.19 | -$0.24 | Miss |
| Mar 4, 2026 | -$0.15 | -$0.08 | Beat |
| Nov 6, 2025 | -$0.26 | -$0.16 | Beat |
| Aug 7, 2025 | -$0.25 | -$0.23 | Beat |
| May 8, 2025 | -$0.29 | -$0.28 | Beat |